ITF, that has no meaning.
We know since the ASM that Bavi Breast is or NEXT candidate (even just before Liver).
Yet it is also no longer on the companies Fact sheet.
You try to draw conclusions where there are non. If the CEO says that they are interested in Bavi+Cotara then they are interested in Bavi+Cotara.
The fact-sheet is a periodically updated document that should reflect the FOCUS of the company which currently is Bavi in SUNRISE and Bavi in Immuno-Oncology and a now apparently better progressing Bavi Digital Imaging.
Cotara is in the wait-for partner for start of PIII and that isn't a bad thing as such if it doesn't stay there endlessly. Cotara was said to be under the dust till it suddenly got approved by the FDA for PIII.
So you see, momentum, momentum, momentum arguments ALWAYS COUNTERED WHEN THE FACT OCCUR. Such as Bavi was a placebo, it would never pass PII, we will never be able to enrol 582 this century, etc, etc, etc.
News 
Market Data 
Discover 
